<DOC>
	<DOCNO>NCT01874769</DOCNO>
	<brief_summary>Recessive Dystrophic Epidermolysis Bullosa ( RDEB ) one severe rare inherit skin disorder affect child adult . Current medical care protocol RDEB patient limit palliative procedure treat blister erosive lesion , wound , severe local systemic complication fusion contracture digit , skin cancer , esophageal stricture , severe anemia , infection , malnutrition growth retardation . However , current medical treatment still prevent recurrence lesion arise defective expression type VII collagen ( COL7A1 ) , main constituent anchor fibril form essential structure dermal-epidermal adherence . The purpose study investigate capacity keratinocytes fibroblast repair skin wound patient suffer Recessive Dystrophic Epidermolysis Bullosa ( RDEB ) .</brief_summary>
	<brief_title>Study Immune Tolerance Capacity Wound Healing Patients With Recessive Dystrophic Epidermolysis Bullosa ( RDEB )</brief_title>
	<detailed_description>In perspective future therapeutic intervention , could involve protein , cellular and/or gene therapy , essential investigate RDEB patient regard immune tolerance type VII collagen capacity cell tissue reconstruction .</detailed_description>
	<mesh_term>Epidermolysis Bullosa</mesh_term>
	<mesh_term>Epidermolysis Bullosa Dystrophica</mesh_term>
	<criteria>Confirmed molecular diagnosis recessive dystrophic epidermolysis bullosa , establish allele ; Non severe generalize clinical form RDEB ; Presence type VII collagen skin biopsy and/or westernblot analysis detect set specific antibody ; Presence intact skin area without blister , infection erosion ; Absence hospitalization relate EB condition ; Patients parent applicable able willing return follow ; Patients able willing give sign informed consent . For patient minor , informed consent sign legally authorize representative , well assent form minor patient . Ability undergo local anesthesia . Severity disease presence illprognostic feature : 1 . Premature termination codon noncollagenous ( NC1 ) domain COL7A1 allele ; 2 . Absence detectable type VII collagen expression skin biopsy Western blot analysis culture cell ; Underlying condition , disease active infection likely increase risk complication interfere biological investigation : 1 . History current previous skin cancer ( Squamous cell carcinoma malignant skin cancer ) ; 2 . Current infectious disease , include systemic infection know positive HIV serology ( Kaposi 's sarcoma ) , hepatitis B C ; 3 . History current psychological psychiatric disease ; 4 . Absence adequate familial social support ; 5 . History current previous organ diabetes mellitus ; 6 . Non correct severe anemia ( Hemoglobin level : &lt; 8 g/ml ) ; 7 . Non correct iron deficiency ; 8 . History significant allergy anaesthetic procedure 9 . Patient currently receive anticoagulant antiaggregation treatment ; 10 . Participation another clinical trial therapy protocol RDEB time study inclusion 11 . Positive pregnancy urinary test lactate woman Not affiliated national social security/health service beneficiary family beneficiary child .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>RDEB</keyword>
	<keyword>COL7A1</keyword>
	<keyword>Collagen VII</keyword>
</DOC>